Neurocrine Biosciences Inc (NASDAQ:NBIX) showed up in the 13F filings of 706 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 124,367 | 0.98% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | -6,258 | -0.06% | $0.00 |
| Bellevue Group AG | 31 Dec, 2025 | 0 | -59,801 | -3.39% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 594,542 | 306.55% | $0.00 |
| DODGE & COX | 31 Dec, 2025 | 0 | -48,576 | -0.87% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | 618,956 | 169.78% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -233,328 | -48.05% | $0.00 |
| Jpmorgan Chase & Co | 31 Dec, 2025 | 0 | -4,259,948 | -45.03% | $0.00 |
| Pictet Asset Management Holding SA | 31 Dec, 2025 | 0 | 83,488 | 12.04% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | -47,073 | -25.63% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | -103,798 | -2.39% | $0.00 |
| BRAIDWELL LP | 31 Dec, 2025 | 0 | -128,748 | -14.63% | $0.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 0 | 498,058 | 17.96% | $0.00 |
| IEQ CAPITAL, LLC | 31 Dec, 2025 | 0 | 52,512 | 7.58% | $0.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 0 | -179,500 | -7.42% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 34,457 | 1.70% | $0.00 |
| Allspring Global Investments Holdings, LLC | 31 Dec, 2025 | 0 | -43,009 | -11.25% | $0.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 0 | -67,202 | -3.71% | $0.00 |
| Nuveen, LLC | 31 Dec, 2025 | 0 | 41,819 | 17.07% | $0.00 |
| BNP Paribas Asset Management Holding S.A. | 31 Dec, 2025 | 0 | 447,869 | 47.24% | $0.00 |